Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Asthma Control in Severe Asthma Patients Treated With Tezepelumab: A Prospective, Observational, Real-World Evidence Study (ASCENT)

NCT05677139 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05677139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Asthma Control in Severe Asthma Patients Treated With Tezepelumab: A Prospective, Observational, Real-World Evidence Study (ASCENT)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 13, 2022
Completion date
February 27, 2026
Enrollment
513 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

asthma